Trevi Therapeutics
TRVI
#7762
Rank
A$0.34 B
Marketcap
$4.77
Share price
0.63%
Change (1 day)
60.82%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$58.65 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$42.8 Million a decrease over its 2022 earnings that were of -A$41.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$58.65 Million37.04%
2023 -A$42.8 Million2.43%
2022 -A$41.78 Million-14.45%
2021 -A$48.84 Million1.36%
2020 -A$48.19 Million23.64%
2019 -A$38.97 Million27.54%
2018 -A$30.56 Million